Forum for Science, Industry and Business
Sponsored by:     Siemens  n-tv 
Search our Site:

Topic (optional):

 

Home Reports Life Sciences Content

Test of bacteria toxin delivery system designed by Hebrew University researchers could pave way for new antibiotic drugs

next article
17.06.2008

Researchers at the Hebrew University of Jerusalem have achieved a breakthrough in monitoring the toxin-delivery system of highly pathogenic bacteria – an accomplishment that could help pave the way for new drugs that will be capable of neutralizing those germs.

 

Most bacteria are harmless and do not cause infections. Some, however, are pathogenic and are equipped with special accessories that are used to deliver toxins (also termed “effectors”) into the cells of the infected person.


...more about:
bacteria syringe

Numerous bacteria that cause disease, ranging from food poisoning to life threatening infection, employ a syringe-like nano-organelle (a specialized part of a cell having a specific function) that is used to inject toxic effectors into attacked host cells. This process is termed a type III secretion system (TTSS). Among these pathogens are Salmonella; the cause of typhoid fever, Yersinia; and enteropathogenic (intestinal) E. coli, which is responsible for the death of up to one million infants per year, mostly in developing countries.

The bacterial syringe employed by these bacteria is an excellent potential target for drugs (not yet available) to combat these diseases. In order to develop such drugs, however, a better understanding of the syringe functions is needed, requiring development of better methods for measuring the syringe activity.

The Hebrew University researchers – Ilan Rosenshine, the Etta Rosensohn Professor of Bacteriology at the Hebrew University Faculty of Medicine, and his associates -- Erez Mills, Kobi Baruch, Xavier Charpentier and Simi Kobi -- have designed a new, real-time test that allows monitoring the syringe activity. Using this test, they have discovered new properties of this system, which might be used to develop drugs that will inhibit the syringe activity and thereby prevent disease and infection by these dangerous pathogens

Their achievement was described in a recent article in the journal Cell Host & Microbe.

Jerry Barach | Source: The Hebrew University of Jerusal
Further information: www.huji.ac.il

Further Reports about: bacteria syringe

next article

More articles from Life Sciences:

nachricht New cancer target for non-Hodgkin's lymphoma
24.11.2009 | New York- Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College

nachricht New hydrogen-storage method discovered
24.11.2009 | Carnegie Institution

All articles from Life Sciences >>>

B2B Search

Product / Service
Company / Organisation

Latest News

Daycare may double TV time for young children

24.11.2009 | Studies and Analyses

Insomnia prevalent among cancer patients who receive chemotherapy

24.11.2009 | Studies and Analyses

How green is your house?

24.11.2009 | Social Sciences

VideoLinks

Event News

Multidisciplinary meeting on Urological Cancers aims to benefit cancer patients

20.11.2009 | Event News

'Golden Age' for clinical psychology in Northern Ireland

20.11.2009 | Event News

New Perspectives in Marine Anti-Fouling Research

11.11.2009 | Event News